G281-2315 Screening compound: N~5~-(2-fluorophenyl)-4-(4-methoxyphenyl)-9-methyl-7,8,9,10-tetrahydro-4H-pyrido[4',3':4,5]thieno[3,2-f]pyrrolo[1,2-a][1,4]diazepine-5(6H)-carboxamide

G281-2315 Screening compound: N~5~-(2-fluorophenyl)-4-(4-methoxyphenyl)-9-methyl-7,8,9,10-tetrahydro-4H-pyrido[4',3':4,5]thieno[3,2-f]pyrrolo[1,2-a][1,4]diazepine-5(6H)-carboxamide
G281-2315 Screening compound: N~5~-(2-fluorophenyl)-4-(4-methoxyphenyl)-9-methyl-7,8,9,10-tetrahydro-4H-pyrido[4',3':4,5]thieno[3,2-f]pyrrolo[1,2-a][1,4]diazepine-5(6H)-carboxamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G281-2315
N~5~-(2-fluorophenyl)-4-(4-methoxyphenyl)-9-methyl-7,8,9,10-tetrahydro-4H-pyrido[4',3':4,5]thieno[3,2-f]pyrrolo[1,2-a][1,4]diazepine-5(6H)-carboxamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G281-2315

Molecular Formula

C28H27FN4O2S (C28 H27 FN4 O2 S)

Compound Name

N~5~-(2-fluorophenyl)-4-(4-methoxyphenyl)-9-methyl-7,8,9,10-tetrahydro-4H-pyrido[4',3':4,5]thieno[3,2-f]pyrrolo[1,2-a][1,4]diazepine-5(6H)-carboxamide

IUPAC name

N-(2-fluorophenyl)-7-(4-methoxyphenyl)-14-methyl-17-thia-2814-triazatetracyclo[8.7.0.0^{26}.0^{1116}]heptadeca-1(10)3511(16)-tetraene-8-carboxamide

SMILES

CN(CC1)Cc2c1c(CN(C(c1cccn1-1)c(cc3)ccc3OC)C(Nc(cccc3)c3F)=O)c1s2

InChI

InChI=1S/C28H27FN4O2S/c1-31-15-13-20-21-16-33(28(34)30-23-7-4-3-6-22(23)29)26(18-9-11-19(35-2)12-10-18)24-8-5-14-32(24)27(21)36-25(20)17-31/h3-12,14,26H,13,15-17H2,1-2H3,(H,30,34)/t26-/m0/s1

InChI Key

KTFRPVLBLKAFQA-SANMLTNESA-N

MDL Number (MFCD)

MFCD27212654

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

502.61

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

5.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.672

Distribution Coefficient, logD

3.908

Water Solubility, LogSw

-5.45

Polar Surface Area

37.199

Acid Dissociation Constant (pKa)

12.90

Base Dissociation Constant (pKb)

9.16

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

25.00

G281-2315 in Drug Discovery

Included in Screening Libraries

Allosteric Kinases Inhibitors Library (23117 compounds)

Protein-Protein Interaction Library (218420 compounds)

Recognition Elements PPI Library (24135 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Female
  • Congenital
  • Skin
Targets:
  • Kinases
Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with G281-2315 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G281-2315?
Check Price and Availability of G281-2315, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G281-2315 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G281-2315
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G281-2315
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G281-2315 available by request